00
Days
00
Hrs
00
Min
00
Sec
Submit Your Paper

Predictors of COVID-19 Mortality: A Stratified 3 by 3 Factorial Correlation Analysis

Authors

Wilfred Omwansa Arori

Maseno University, School of Mathematics Statistics and Actuarial Science (KE)

Article Information

DOI: 10.51583/IJLTEMAS.2026.150500133

Subject Category: Statistics

Volume/Issue: 15/5 | Page No: 1680-1695

Publication Timeline

Submitted: 2026-06-08

Published: 2026-06-08

Abstract

In this paper the strength of association of some factors with COVID-19 mortality across countries is examined. This is essential for future pandemic preparedness. In this study, a 3 × 3 factorial design where 36 countries were stratified by GDP per capita and population density was used. Secondary data were sourced from the World Bank, United Nations, and Our World in Data repositories. A parsimonious linear regression model with four predictors: positivity rate, vaccination coverage, log (GDP per capita), and median age was fitted. Bootstrapping provided 95% confidence intervals. Low-GDP countries had higher positivity rates (10.2% vs. 3.0%) but lower reported deaths (167 vs. 1,186 per million) than high-GDP countries. The model explained 89.2% of variance (adjusted R² = 0.878, p < 0.001). Positivity rate was the strongest predictor of mortality (β = 10.51, p < 0.001), followed by GDP per capita (β = 1.39, p < 0.001). The positivity-deaths correlation was strongest in high-GDP countries (r = 0.898, p < 0.001) compared to low-GDP countries (r = 0.597, p = 0.019), suggesting that differential death reporting attenuates associations in low-resource settings. These findings suggest positivity rate as a high value predictor of COVID-19 mortality. Maintaining low positivity rates through accessible testing should guide future pandemic surveillance.

Keywords

COVID -19, positivity rate, testing, vaccination, GDP

Downloads

References

1. World Health Organization. (2020). Public health criteria to adjust public health and social measures in the context of COVID-19. WHO. https://www.who.int/publications/i/item/WHO-2019-nCoV-Adjusting_PH_measures-Criteria-2020.1 [Google Scholar] [Crossref]

2. Msemburi, W., Karlinsky, A., Knutson, V., Aleshin-Guendel, S., Chatterji, S., & Wakefield, J. (2023). The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature, 613(7942), 130-137. https://doi.org/10.1038/s41586-022-05522-2 [Google Scholar] [Crossref]

3. Klement, R. J., & Walach, H. (2022). Testing and vaccination to reduce COVID-19 mortality in European countries. Journal of Clinical Medicine, 11(15), 4384. https://doi.org/10.3390/jcm11154384 [Google Scholar] [Crossref]

4. Abbasi, A. F., Karimi Dehkordi, N., SoleimanvandiAzar, N., Roohravan Benis, M., & Nojomi, M. (2025). Gini coefficient, GDP per capita and COVID-19 mortality: a systematic review of ecologic studies. BMC Public Health, 25(1), 22921. https://doi.org/10.1186/s12889-025-22921-4 [Google Scholar] [Crossref]

5. Kanokudom, S., Piamsa-Nga, N., Ratanapanich, K., et al. (2025). Impact of economic factor, percent vaccination, healthcare quality, and population density on coronavirus disease 2019 (COVID-19) mortality rates: a global analysis in 2023. Cureus, 17(3), e80582. https://doi.org/10.7759/cureus.80582 [Google Scholar] [Crossref]

6. Wang, L., Ma, H., Yiu, K. C. Y., Calzavara, A., Landsman, D., Luong, L., Chan, A. K., Kustra, R., Kwong, J. C., Boily, M. C., Hwang, S., Straus, S., Baral, S. D., & Mishra, S. (2020). Heterogeneity in testing, diagnosis and outcome in SARS-CoV-2 infection across outbreak settings in the Greater Toronto Area, Canada: an observational study. CMAJ Open, 8(4), E627-E636. https://doi.org/10.9778/cmajo.20200097 [Google Scholar] [Crossref]

7. Stocki, S. A., Alvarenga, M. B. B., Pinheiro, D. S., Salles, M. V., Machado, G. C., Oliveira Filho, N. C., Bif, N. C. S., & Freitas, J. B. C. (2026). Impact of COVID-19 vaccination on SARI lethality among older adults in Brazil: an ecological study (2020-2023). The Brazilian Journal of Infectious Diseases. https://doi.org/10.1016/j.bjid.2026.103456 [Google Scholar] [Crossref]

8. Aguilar, S., Bastos, L. S. L., Maçaira, P., Baião, F., Simões, P., Cerbino-Neto, J., Ranzani, O., Hamacher, S., & Bozza, F. A. (2024). Impact of the first year of COVID-19 vaccination strategy in Brazil: an ecological study. BMJ Open, 14(7), e072314. https://doi.org/10.1136/bmjopen-2023-072314 [Google Scholar] [Crossref]

9. Buttia, C., Llanaj, E., Raeisi-Dehkordi, H., Kastrati, L., Amiri, M., Meçani, R., Taneri, P. E., Ochoa, S. A. G., Raguindin, P. F., Wehrli, F., Khatami, F., Espínola, O. P., Rojas, L. Z., de Mortanges, A. P., Macharia-Nimietz, E. F., Alijla, F., Minder, B., Leichtle, A. B., Lüthi, N., Ehrhard, S., Que, Y. A., Fernandes, L. K., Hautz, W., & Muka, T. (2023). Prognostic models in COVID-19 infection that predict severity: a systematic review. European Journal of Epidemiology, 38(4), 355-372. https://doi.org/10.1007/s10654-023-00973-1 [Google Scholar] [Crossref]

10. Appel, K. S., Geisler, R., Maier, D., Miljukov, O., Hopff, S. M., & Vehreschild, J. J. (2024). A systematic review of predictor composition, outcomes, risk of bias, and validation of COVID-19 prognostic scores. Clinical Infectious Diseases, 78(4), 889-899. https://doi.org/10.1093/cid/ciad618 [Google Scholar] [Crossref]

11. Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155-159. https://doi.org/10.1037/0033-2909.112.1.155 [Google Scholar] [Crossref]

12. Hair, J. F., Black, W. C., Babin, B. J., & Anderson, R. E. (2010). Multivariate data analysis (7th ed.). Pearson Prentice Hall. [Google Scholar] [Crossref]

13. Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., Bailey, R., Swanson, K. A., Roychoudhury, S., Koury, K., Li, P., Kalina, W. V., Cooper, D., Frenck, R. W., Hammitt, L. L., & Gruber, W. C. (2020). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine, 383(27), 2603-2615. https://doi.org/10.1056/NEJMoa2034577 [Google Scholar] [Crossref]

14. Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., McGettigan, J., Khetan, S., Segall, N., Solis, J., Brosz, A., Fierro, C., Schwartz, H., Neuzil, K., Corey, L., & Zaks, T. (2021). Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of Medicine, 384(5), 403-416. https://doi.org/10.1056/NEJMoa2035389 [Google Scholar] [Crossref]

15. Rahmanian Haghighi, M. R., Ghasemi, A., & Mokhtari, M. (2024). Factors associated with COVID-19 excess mortality: A cross-country analysis. Journal of Global Health, 14, 05012. https://doi.org/10.7189/jogh.14.05012 [Google Scholar] [Crossref]

16. Thorp, H., Miller, B., & Johnson, C. (2023). Global correlates of COVID-19 mortality: A multi-country ecological study. BMJ Global Health, 8(3), e011245. https://doi.org/10.1136/bmjgh-2022-011245 [Google Scholar] [Crossref]

17. Knipper, M., Moreira-Soto, A., Beuchel, C., Tabares, X., Wulf, B., Gade, N., Fischer, C., Aigner, A., & Drexler, J. F. (2025). Socioeconomic determinants potentially underlying differential global SARS-CoV-2 testing capacity: an ecological study. BMJ Open, 15(3), e090804. https://doi.org/10.1136/bmjopen-2024-090804 [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles

© 2026 IJLTEMAS · RSIS International. All rights reserved. ISSN 2278-2540.